A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
Clinical trial NCT00650611 · COMPLETED
Trial details
- NCT number
- NCT00650611
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.